![Blood Podcast artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/02/82/f4/0282f4cd-40ab-c4eb-7ebd-ab26ffec617e/mza_15952236382953722746.jpg/100x100bb.jpg)
Immune thrombocytopenia and adenoviral SARS-COV2 vaccines, genomics, and a risk assessment model of anti-CD19 CAR T-cell treatment outcomes in lymphoma
Blood Podcast
English - August 04, 2022 16:30 - 20 minutes - 18.9 MB - ★★★★ - 44 ratingsLife Sciences Science hematology oncology medical medical research Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
In this week’s episode we’ll discuss the factors influencing the development of immune thrombocytopenia after administration of the ChAdOx1 nCov-19 vaccine, learn about the genomic features underlying anti-CD19 CAR T-cell treatment failure in lymphoma, and introduce a new predictive model for risk assessment before CAR T-cell therapy for large B-cell lymphoma.